Hepatus Series
Non-invasive fibrosis evaluation system
This device series opens up a new era for non-invasive liver disease diagnosis. It is suitable for the quantitative diagnosis of liver fibrosis and fatty liver caused by various chronic liver diseases. It supports early detection, diagnosis, treatment, and rehabilitation of various chronic liver diseases. Recommend by global liver disease guidelines, non-invasive quantitative analysis of fibrosis is the first step in chronic liver disease assessment.
Client / Manufacturer
Design
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Shenzhen, CNShenzhen Mindray Bio-Medical Electronics Co., Ltd.
Shenzhen, CNDate of Launch
2020
Development Time
25 - 36 months
Target Regions
Asia, Europe, North America, South America
Target Groups
Consumer / User